BillionToOne private stock trade

BillionToOne

Legal NameBillionToOne, Inc.
HeadquartersMenlo Park, CA
SectorBioTech

BillionToOne is a biotechnology company specializing in molecular diagnostics and genetic testing solutions. The company offers innovative technologies designed to detect genetic abnormalities and diseases with high accuracy and precision. BillionToOne's expertise lies in leveraging advanced molecular biology and bioinformatics to develop cutting-edge diagnostic assays and testing platforms. The company aims to empower healthcare professionals and patients by providing user-friendly and highly sensitive genetic testing solutions that enable early detection, diagnosis, and monitoring of genetic conditions, ultimately contributing to improved patient outcomes and personalized healthcare.

Learn more about BillionToOne IPO

Secondary Pricing Information

$ .star in blue circleZX Index Value | Get ZXData access
--ZX Index Value MoM Change
--ZX Index Value VS Reported Marks
pricing graph placeholder
star in blue circleTo view Pre-IPO pricing data for BillionToOne, log in to ZXData or contact us to request access.
<

Secondary Volume Information

$ .M star in blue circleAggregate Volume | Get ZXData access
volume graph placeholder
star in blue circleTo view Pre-IPO volume data for BillionToOne, log in to ZXData or contact us to request access.
View More

ZXData is the leading provider of real-time secondary data on private companies. ZXData has the largest dataset of closed trades with $15bn+ in volume. In addition, it incorporates $150bn+ of buy/sell prices and $45bn+ of reported marks to provide private market investors, trading desks, lenders, and companies with unprecedented market intelligence on private companies.